Form 4: SI-BONE Executive Sells Shares for Tax Obligations

SI-BONE's SVP, Ops & Adm/Chief Legal Officer, Michael A. Pisetsky, sold common stock on October 2, 2025, to cover tax withholding obligations from restricted stock unit vesting.

Summary

• Michael A. Pisetsky, SVP, Operations & Administration/Chief Legal Officer of SI-BONE, Inc. (SIBN), reported sales of common stock.
• The transactions occurred on October 2, 2025.
• A total of 3,128 shares of common stock were sold across three separate transactions.
• The sales were executed at weighted average prices of $14.255, $14.1053, and $14.2537 per share.
• These sales were non-discretionary, specifically to cover tax withholding obligations related to the vesting of restricted stock units.
• Following these transactions, Michael A. Pisetsky beneficially owns 255,224 shares of common stock directly.
• This beneficial ownership includes 132,362 shares issuable upon the settlement of restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While shares were sold, it was a non-discretionary 'sell to cover' transaction for tax purposes, which is a routine event for executive compensation. The underlying vesting of restricted stock units is a positive for the executive, reflecting earned compensation.

Positives

• The vesting of restricted stock units indicates the achievement of performance milestones or tenure requirements for the executive.
• The 'sell to cover' mechanism is a standard and transparent way for executives to manage tax liabilities arising from equity compensation.

Negatives

• No direct negatives are identified from this specific filing, as the sale was non-discretionary for tax purposes.

Risks

• Misinterpretation by the market: Despite the clear explanation, some investors might misinterpret the insider sale as a lack of confidence in the company, potentially leading to short-term negative sentiment.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• The sale satisfies the tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

Insider transactions, particularly 'sell to cover' sales for tax obligations related to RSU vesting, are common across all industries for publicly traded companies. They reflect standard executive compensation practices and tax management rather than specific industry trends.

Comparison to Industry Standards

• The 'sell to cover' transaction is a widely accepted and standard practice for executives in public companies globally to manage tax liabilities arising from equity compensation.
• It aligns with typical corporate governance and compensation structures seen in comparable medical device or healthcare technology companies, such as Stryker Corporation (SYK) or Zimmer Biomet Holdings (ZBH), where executives also receive equity awards that trigger similar tax obligations upon vesting.

Stakeholder Impact

• Shareholders: Minimal direct impact as it is a non-discretionary tax-related sale, not indicative of a change in management's confidence. Could be misinterpreted if the explanation is overlooked.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• This filing does not specify any future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Recommendation

This Form 4 reports a routine 'sell to cover' transaction by an executive to satisfy tax obligations upon the vesting of restricted stock units. It is not a discretionary sale and therefore does not reflect a change in the executive's confidence in the company's future prospects. As such, this filing alone provides no new fundamental information to warrant a change in investment recommendation. Investors should hold their positions and consider broader company performance and market conditions.

Keywords

SI-BONE, SIBN, Form 4, insider transaction, stock sale, executive compensation, restricted stock units, tax withholding, Michael A. Pisetsky, corporate governance